Skip to main content
Caplight Logo









ArteryFlow Technology

ArteryFlow Technology

Private
HangzhouHealthcare & Life Scienceshttps://www.arteryflow.com/

Last Round

Series B

Dec 10, 2021

Total Funding Raised

$21.23M

Company Overview

ArteryFlow Technology is a medical technology company that develops intelligent diagnostic and treatment planning solutions for cardiovascular and cerebrovascular diseases using AI and computational fluid dynamics.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

medical imaging softwarecomputational fluid dynamicsCFDcardiovascular AIsurgical planning softwarehemodynamic assessmentmedical AIcoronary functional assessmentintracranial aneurysmdigital twinnon-invasive diagnosticsclinical decision supportmedical device softwareAI-driven radiologyhealthcare analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ArteryFlow Technology Comparables

Compare ArteryFlow Technology with similar companies based on industry and business-model similarity.

ArteryFlow Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pulse Medical Imaging Technology
86%
Raysight Medical
83%
Medis Medical Imaging Systems
82%

ArteryFlow Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 10, 2021
Series A ExtensionDec 30, 2019
Series ASep 6, 2019
AngelDec 27, 2018

Key People

Founding team and executive leadership

Jianping Xiang

Founder and CEO

Founding Team

ArteryFlow Technology Investors

Notable investors and investment history

ArteryFlow Technology investors
InvestorRounds
健壹资本Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 30, 2023

    Grew 133% QoQ, from 9 to 21 employees.

  • Dec 30, 2019

    $4.3M round with participation from Sinopharm Capital.

ArteryFlow Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ArteryFlow Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ArteryFlow Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range18
Year Founded2017
Last FundingDec 10, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.